MicrobiologybioRxivPreprint
Human anti-ACE2 monoclonal antibodies as pan-sarbecovirus prophylactic agents
F. Zhang, J. Jenkins, R. V. H. de Carvalho…·P. D. Bieniasz
The paper develops human monoclonal antibodies targeting the ACE2 receptor to block infection by SARS-CoV-2 and related sarbecoviruses, showing broad efficacy against variants and no adverse effects on ACE2 function.
DOI 10.1101/2022.08.24.505169